在JF305细胞中,敲降MSX2则MRP2表达降低(0.69±0.17);在PANC-1细胞中,过表达MSX2则MRP2表达升高(2.1±0.31).结论 成功建立了2株稳定的耐药胰腺癌细胞株JF305/CDDP和PANC-1/GEM.发现了新的耐药相关基因MSX2,MSX2可能通过上调MRP2的表达促进胰腺癌细胞耐药.%Objective To explore new multidrug resistant genes of...
产品名称:DSPE-mPEG修饰的吉西他滨和顺铂双载药脂质体(mPEG-gemcitabine/cisplatin liposomes,mPEG-GEM/CDDP-LP),储存温度:2°C-8°C(不要冻结),提供定制服务货号规格数量价格 Q-0284718 100mg 1 询价 Q-0284718 250mg 1 询价 Q-0284718 500mg 1 询价 Q-0284718 1g 1 询价 Q-0284718 5g 1 询价 快速...
AITKEN C, Recht A, Stuart K. Concurrent cisplatin (CDI)P), gemcitabine (GEM) and external beam radiation therapy (EBRT) in the treatment of locally advanced pancreatic or periampullary cancer: tolerance and toxicity of treatment. Int J Radiation Oncology Biol Phys 2002:54S:210....
Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial. Lung Cancer 2002; 37:9.Grigorescu AC, Draghici IN, Nitipir C et al. Gemcitabine (GEM) and carboplatin ...
在JF305细胞中,敲降MSX2则MRP2表达降低(0.69±0.17);在PANC-1细胞中,过表达MSX2则MRP2表达升高(2.1±0.31).结论 成功建立了2株稳定的耐药胰腺癌细胞株JF305/CDDP和PANC-1/GEM.发现了新的耐药相关基因MSX2,MSX2可能通过上调MRP2的表达促进胰腺癌细胞耐药.%Objective To explore new multidrug resistant genes of...
杨春雨田振囡刘炜Yang CY,Tian TN,Liu W,et al. Screening the drug sen- sitivity genes related to GEM and CDDP in the lung can- cer cell-lines[J]. Chinese Journal of Lung Cancer,2009,10 (12): 1061-1068.
Randomized trial of gemcitabine (GEM) alone or with cisplatin (CDDP) in the treatment of advanced pancreatic cancer (APC): a phase II multicenter study of the Southern Italy Oncology Group. Proc ASCO 1999;961.Colucci G, Riccardi F, Giuliani F et al. Randomized trial of gem- citabine (GEM...
Buffoni L,Dongiovanni D,Barone C,et al.A phase II study with cisplatin (cddp) and gemcitabine (gem) in elderly patients with advanced non-small cell lung cancer. Ejc Supplements . 2007Buffoni L,Dongiovanni D,Barone C,et al.A phase II study with cisplatin (cddp) and gemcitabine (gem)...
Feasibility of combination of cisplatin (CDDP) and gemcitabine (GEM) in non-small cell lung cancer and other solid tumors: analysis of dose-intensity (DI) and compliance of four different schedules - European Journal of Cancerdoi:10.1016/S0959-8049(01)80719-XS. P. Hector...
, Phase II activity of cisplatin (CDDP) plus ifosfamide (IFO) and gemcitabine (GEM) in non small cell lung cancer (NSCLC): preliminary results . Acts of the 8th World Conference on Lung Cancer, Dublin 18, 204 (abstract) ( 1997 )....